Babler Martin 4
4 · MapLight Therapeutics, Inc. · Filed Jun 25, 2026
Research Summary
AI-generated summary of this filing
MapLight Therapeutics (MPLT) Director Martin Babler Receives RSU & Option Awards
What Happened
Martin Babler, a director of MapLight Therapeutics (MPLT), received equity awards on June 23, 2026: 7,864 restricted stock units (RSUs) and a derivative award covering 29,804 shares (a stock option). Both awards were granted at $0.00 reported value and were made under the Issuer’s 2025 Equity Incentive Plan as part of the company’s non-employee director compensation policy. These grants are not purchases or sales of stock—they are compensation awards that vest over time.
Key Details
- Transaction date(s): June 23, 2026; Form 4 filed June 25, 2026.
- Reported price/value: $0.00 for both awards (standard for equity grants reported as awards).
- RSUs: 7,864 RSUs; each RSU represents a contingent right to one share. (Footnotes F1, F2)
- Derivative award: 29,804-share stock option (derivative). (Footnote F3)
- Vesting: Both awards vest in three equal annual installments beginning June 23, 2027, subject to continuous service as defined in the plan.
- Compensation policy: Grants made pursuant to the Issuer’s non-employee director compensation policy.
- Shares owned after transaction: Not specified in the supplied filing.
- Filing timeliness: Reported on Form 4 two days after the transaction date; no late filing indicated.
Context
These are compensation grants to a non-employee director, a routine corporate practice to align directors’ interests with shareholders. The derivative entry reflects an option award (a right to acquire shares subject to vesting and later exercise), not an immediate transfer of common stock. Such grants are informational for investors but do not represent a market purchase (which some investors view as a stronger bullish signal).
Insider Transaction Report
- Award
Voting Common Stock
[F1][F2]2026-06-23+7,864→ 7,864 total - Award
Stock Option (right to buy)
[F3]2026-06-23+29,804→ 29,804 totalExercise: $28.64Exp: 2036-06-22→ Voting Common Stock (29,804 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.
- [F2]Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
- [F3]Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.